ARK Genomic Revolution ETF
Cboe: ARKG
The ARK Genomic Revolution ETF is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Funds investment theme of the genomics revolution.
Book Viewer
Book Viewer
| Orders Accepted | Total Volume | Expand All | Select MIC to filter: | |
|---|---|---|---|
| Top of Book | Last 10 Trades | ||||||
|---|---|---|---|---|---|---|---|
| Shares | Price | Time | Price | Shares | |||
| Asks | |||||||
| Bids | |||||||
About ARK Investment Management
ARK Investment Management LLC is a federally registered investment adviser and privately held investment firm. Specializing in thematic investing in disruptive innovation, the firm is rooted in over 40 years of experience in identifying and investing in innovations that should change the way the world works. Through its open research process, ARK identifies companies that it believes are leading and benefiting from cross-sector innovations such as robotics, energy storage, multiomic sequencing, artificial intelligence, and blockchain technology. ARK's investment strategies include Autonomous Technology and Robotics, Next Generation Internet, Genomic Revolution, Fintech Innovation, Space Exploration & Innovation, 3D Printing, Israel Innovative Technology, the overall ARK Disruptive Innovation Strategy, and the ARK Venture Fund. For more information about ARK, its offerings, and original research, please visit www.ark-invest.com.